Viewing Study NCT02555293


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-02-10 @ 10:02 AM
Study NCT ID: NCT02555293
Status: TERMINATED
Last Update Posted: 2021-11-01
First Post: 2015-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver Resection
Sponsor: RWTH Aachen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Liver Disease View
None Major Liver Resection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Liver resection View
None fibrosis View
None inflammation View
None Rifaximin View